Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cannabidiol (CBD) for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
NCT05388058Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Zygel in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Mayo Clinic. Started Jun 2022; status: completed.
02
Drugs
Zygel
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05388058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05388058.